265 related articles for article (PubMed ID: 33920790)
1. Cardiovascular Outcomes in the Acute Phase of COVID-19.
Nakano H; Shiina K; Tomiyama H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920790
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Edmonston DL; South AM; Sparks MA; Cohen JB
Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
[TBL] [Abstract][Full Text] [Related]
4. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
5. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
6. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms.
Abdel-Moneim A
Biochemistry (Mosc); 2021 Apr; 86(4):389-396. PubMed ID: 33941061
[TBL] [Abstract][Full Text] [Related]
8. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
Speer G; Somogyi P
Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
Gilbert RE; Caldwell L; Misra PS; Chan K; Burns KD; Wrana JL; Yuen DA
Can J Diabetes; 2021 Mar; 45(2):162-166.e1. PubMed ID: 32917504
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
Luo J; Zhu X; Jian J; Chen X; Yin K
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link?
Patil M; Singh S; Henderson J; Krishnamurthy P
J Cell Physiol; 2021 May; 236(5):3366-3382. PubMed ID: 33078408
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D
Cardiovasc Res; 2021 Dec; 117(14):2705-2729. PubMed ID: 34528075
[TBL] [Abstract][Full Text] [Related]
15. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
16. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19.
Medzikovic L; Cunningham CM; Li M; Amjedi M; Hong J; Ruffenach G; Eghbali M
J Mol Cell Cardiol; 2020 Nov; 148():25-33. PubMed ID: 32835666
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
Front Immunol; 2020; 11():1714. PubMed ID: 32793244
[TBL] [Abstract][Full Text] [Related]
18. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
Seltzer S
Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Involvement of COVID-19: A Comprehensive Review.
Chang WT; Toh HS; Liao CT; Yu WL
Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]